Helsana HealthInvest

Helsana HealthInvest is a corporate venture capital firm based in Dübendorf, Zurich, Switzerland, investing in digital health startups and venture funds across Europe to enhance the Swiss healthcare system. A subsidiary of Swiss health insurer Helsana, it manages an evergreen fund of CHF 100 million, typically deploying CHF 1–5 million in Series A to B rounds, often leading. It targets scalable models for the Swiss market, offering portfolio companies access to Helsana's ecosystem, which serves 1.4 million individuals and 60,000 corporate clients. Its portfolio includes co-leading Hedera Dx's $17 million Series A and leading Yazen's $21 million Series A alongside Mikael Hed, with Dietrich Aumann as an Investment Manager. Established in 2021, the firm's founders are not publicly known.